Gilead Sciences, Inc. is downgraded to Hold due to uncertainty on the Arcellx acquisition and cell therapy portfolio challenges. Read more on GILD stock here.
HOLLYWOOD--God bless America, and how's everybody?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results